Skip to main content

Advertisement

SpringerLink
Log in

Cystic Fibrosis: Need for Mass Deployable Screening Methods

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR is a member of the adenosine triphosphate (ATP)-binding cassette superfamily of proteins and it functions as a chloride channel. CFTR largely controls the working of epithelial cells of the airways, the gastrointestinal tract, exocrine glands, and genitourinary system. Cystic fibrosis is responsible for severe chronic pulmonary disorders in children. Other maladies in the spectrum of this life-limiting disorder include nasal polyposis, pansinusitis, rectal prolapse, pancreatitis, cholelithiasis, insulin-dependent hyperglycemia, and cirrhosis. This review summarizes the recent state of art in the field of cystic fibrosis diagnostic methods with the help of CF literature published so far and proposes new research domains in the field of cystic fibrosis diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Davis, P. B., Drumm, M., & Konstan, M. W. (1996). State of the art: cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 154, 1229–1256.

    Article  CAS  Google Scholar 

  2. Hamosh, A., Fitz-Simmons, S. C., Macek, M., Jr., et al. (1998). Comparison of the clinical manifestation of cystic fibrosis in black and white patients. Journal of Pediatrics, 132, 255–259.

    Article  CAS  Google Scholar 

  3. Wilcken, B., Wiley, V., Sherry, G., & Bayliss, U. (1995). Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies. Journal of Pediatrics, 127, 965–970.

    Article  CAS  Google Scholar 

  4. Stern, R. C. (1997). The diagnosis of cystic fibrosis. New England Journal of Medicine, 336, 487–491.

    Article  CAS  Google Scholar 

  5. Kliegman, R., & Nelson, W. E. (2011). Nelson textbook of pediatrics (19th ed.). Philadelphia: Elsevier/Saunders.

    Google Scholar 

  6. Rommens, J. M., Iannuzzi, M. C., Kerem, B., et al. (1989). Identification of the cystic fibrosis gene: chromosome walking and jumping. Science, 245, 1059–1065.

    Article  CAS  Google Scholar 

  7. Tsui, L. C. (1995). The cystic fibrosis transmembrane conductance regulator gene. American Journal of Respiratory and Critical Care Medicine, 151, S47–S53.

    Article  CAS  Google Scholar 

  8. Riordan, J. R., Rommens, J. M., Kerem, B., et al. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 245, 1066–1073.

    Article  CAS  Google Scholar 

  9. Rich, D. P., Anderson, M. P., Gregory, R. J., et al. (1990). Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature, 347, 358–363.

    Article  CAS  Google Scholar 

  10. Welsh, M. J., & Smith, A. E. (1993). Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell, 73, 1251–1254.

    Article  CAS  Google Scholar 

  11. Welsh, M. J., Ramsay, B. W., Accurso, F., & Cutting, G. R. (2001). Cystic fibrosis. In A. B. C. Scriver, W. S. Sly, & D. Valle (Eds.), The molecular and metabolic basis of inherited disease (pp. 5121–5188). New York: McGRAW-Hill.

    Google Scholar 

  12. Rich, D. P., Berger, H. A., Cheng, S. H., et al. (1993). Regulation of the cystic fibrosis transmembrane conductance regulator Cl− channel by negative charge in the R domain. Journal of Biological Chemistry, 268, 20259–20267.

    CAS  Google Scholar 

  13. Bear, C. E., Li, C. H., Kartner, N., et al. (1992). Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell, 68, 809–818.

    Article  CAS  Google Scholar 

  14. Mishra, A., Greaves, R., & Massie, J. (2005). The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clinical Biochemist Reviews, 26, 135–153.

    Google Scholar 

  15. The Cystic Fibrosis Genotype-Phenotype Consortium, access 2004; http://www.genet.sickkids.on.ca. Accessed 18 Oct 2005.

  16. Rowntree, R. K., & Harris, A. (2003). The phenotypic consequences of CFTR mutations. Annals of Human Genetics, 67, 471–485.

    Article  CAS  Google Scholar 

  17. Warren, W. S., Hamosh, A., Egan, M., & Rosenstein, B. J. (1997). False-positive results of genetic testing in cystic fibrosis. Journal of Pediatrics, 130, 658–660.

    Article  CAS  Google Scholar 

  18. Zielenski, J. (2000). Genotype and phenotype in cystic fibrosis. Respiration, 67, 117–133.

    Article  CAS  Google Scholar 

  19. LeGrys, V. A. (1996). Sweat testing for the diagnosis of cystic fibrosis: practical considerations. Journal of Pediatrics, 129, 892–897.

    Article  CAS  Google Scholar 

  20. Green. A. (2002). Guidelines for the performance of the sweat test or the investigation of cystic fibrosis in the UK. UKNEQAS.

  21. NCCLS. (2000). Sweat testing: Sample collection and quantitative analysis; approved guideline – second edition. Document C34-A2. Wayne: The Committee.

  22. Hodson, M. E., Beldon, I., Power, R., Duncan, F. R., Bamber, M., & Batten, J. C. (1983). Sweat tests to diagnose cystic fibrosis in adults. British Medical Journal (Clinical Research Ed), 286, 1381–1383.

    Article  CAS  Google Scholar 

  23. The Sweat Testing Working Party. Australian guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis 2004; www.aacb.asn.au. Accessed 18 Oct 2005.

  24. Cystic Fibrosis Foundation Center Director Committee, Update I, Bethesda, Maryland;1990.

  25. Heeley, M. E., Woolf, D. A., & Heeley, A. F. (2000). Indirect measurements of sweat electrolyte concentration in the laboratory diagnosis of cystic fibrosis. Archives of Disease in Childhood, 82, 420–424.

    Article  CAS  Google Scholar 

  26. Rosenstein, B. J., & Langbaum, T. S. (1987). Misdiagnosis of cystic fibrosis. Need for continuing follow-up and reevaluation. Clinical Pediatrics, 26, 78–82.

    Article  CAS  Google Scholar 

  27. Davis, P. B. (2001). Cystic fibrosis. Pediatrics in Review, 22, 257–264.

    Article  CAS  Google Scholar 

  28. Dorota, S. (2013). Transepithilial Nasal Potential Difference(NPD) measurements in cystic fibrosis. Development Period Medicine, 17, 13–17.

    Google Scholar 

  29. Vermeulen, F., Feyaerts, N., Proesmans, M., & De Boeck, K. (2009). Comparison of nasal potential difference measurements done at the nasal floor and under the inferior turbinate: repeatability. Journal of Cystic Fibrosis, 8(2), S10.

    Google Scholar 

  30. Wang, L., & Freedman, S. D. (2002). Laboratory tests for the diagnosis of cystic fibrosis. American Journal of Clinical Pathology, 117(Suppl 1), S109–S115.

    Google Scholar 

  31. Naehrlich, L., Ballmann, M., et al. (2014). Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey. Journal of Cystic Fibrosis, 13, 24–28.

    Article  Google Scholar 

  32. Pollitt, R. J., & Others (1997). Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technology Assessment, Vol1:No.7

  33. Soave, D., Miller, M., Keenan, K., Li, W., et al. (2014). Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study. Diabetes. doi:10.2337/db13-1464.

    Google Scholar 

  34. Dhondt, J. L., Farriaux, J. P., Briard, M. L., Boschetti, R., & Frezal, J. (1993). Results of pilot screening activities in the French neonatal screening program—cystic fibrosis, congenital adrenal hyperplasia and sickle cell disease. Screening, 2, 87–97.

    Article  Google Scholar 

  35. Heeley, A. F., & Bangert, S. K. (1992). The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood. Annals of Clinical Biochemistry, 29, 361–376.

    Article  Google Scholar 

  36. Catalán, M. A., Nakamoto, T., Gonzalez-Begne, M., Camden, J. M., Wall, S. M., Clarke, L. L., et al. (2010). CFTR and ENaC ion channels mediate NaCl absorption in the mouse submandibular gland. Journal of Physiology, 588(Pt 4), 713–724.

    Article  Google Scholar 

  37. Greabu, M., Battino, M., Mohora, M., Totan, A., Didilescu, A., Spinu, T., et al. (2009). Saliva-a diagnostic window to the body, both in health and in disease. Journal of Medicine and Life, 2(2), 124–132.

    Google Scholar 

  38. Pfaffe, T., Cooper-White, J., Beyerlein, P., Kostner, K., & Punyadeera, C. (2011). Diagnostic potential of saliva: current state and future applications. Clinical Chemistry, 57(5), 675–687.

    Article  CAS  Google Scholar 

  39. Chiappin, S., Antonelli, G., Gatti, R., & De Palo, E. F. (2007). Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clinica Chimica Acta, 383(1–2), 30–40.

    Article  CAS  Google Scholar 

  40. Devi, T. J. (2014). Saliva—a potential diagnostic tool. IOSR Journal of Dental and Medical Sciences, 13, 52–57.

    Article  Google Scholar 

Download references

Acknowledgments

Authors are thankful to Prof. G.S. Sengar, SPMC Bikaner India and Dr. R.S. Sengar MGSDC Sri Ganganagar India for reading the text, their constructive criticisms and comments, and valuable discussion and support.

Author information

Authors and Affiliations

  1. Department of Electronics and Communication, The LNM Institute of Information Technology, Jaipur, 302031, India

    Aditya Singh Sengar & Anirudh Agarwal

  2. Department of Physics, The LNM Institute of Information Technology, Jaipur, 302031, India

    Manish K. Singh

Authors
  1. Aditya Singh Sengar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anirudh Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manish K. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Aditya Singh Sengar or Manish K. Singh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sengar, A.S., Agarwal, A. & Singh, M.K. Cystic Fibrosis: Need for Mass Deployable Screening Methods. Appl Biochem Biotechnol 174, 1127–1136 (2014). https://doi.org/10.1007/s12010-014-0991-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-014-0991-2

Keywords

Search

Navigation